Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 16,696 | 14,729 | 10,874 | 7,158 | 4,169 |
| Cost of Goods | 2,615 | 2,610 | 1,790 | 1,061 | 775 |
| Gross Profit | 14,081 | 12,119 | 9,084 | 6,097 | 3,394 |
| Operating Expenses | 70,878 | 80,406 | 285,106 | 53,219 | 56,184 |
| Operating Income | -56,182 | -67,677 | -275,232 | -47,061 | -52,015 |
| Interest Expense | 4,488 | 4,420 | 4,351 | 4,179 | 4,290 |
| Other Income | 9,362 | 2,348 | 3,234 | 3,153 | 1,369 |
| Pre-tax Income | -51,308 | -69,749 | -276,349 | -48,087 | -54,936 |
| Income Tax | -1,392 | -541 | -164,683 | 49 | 56 |
| Net Income Continuous | -49,916 | -69,208 | -111,666 | -48,136 | -54,992 |
| Net Income | $-49,916 | $-69,208 | $-111,666 | $-48,136 | $-54,992 |
| EPS Basic Total Ops | -0.28 | -0.43 | -0.69 | -0.34 | -0.39 |
| EPS Basic Continuous Ops | -0.28 | -0.44 | -0.69 | -0.34 | -0.39 |
| EPS Diluted Total Ops | -0.28 | -0.43 | -0.69 | -0.34 | -0.39 |
| EPS Diluted Continuous Ops | -0.28 | -0.44 | -0.69 | -0.34 | -0.39 |
| EBITDA(a) | $-52,612 | $-64,046 | $-271,918 | $-43,936 | $-48,789 |